Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 80Rectal Neoplasms 40Colonic Neoplasms 34Pancreatic Neoplasms 27Stomach Neoplasms 22Carcinoma, Hepatocellular 21Breast Neoplasms 21Esophageal Neoplasms 20Neoplasm Metastasis 18Nasopharyngeal Carcinoma 15Esophageal Squamous Cell Carcinoma 13Neoplasms 7Head and Neck Neoplasms 7Liver Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Squamous Cell 5Anus Neoplasms 5Adenocarcinoma Of Esophagus 5Nasopharyngeal Neoplasms 4Inflammatory Breast Neoplasms 4Cholangiocarcinoma 4Recurrence 3Gallbladder Neoplasms 3Breast Neoplasms, Male 3Bile Duct Neoplasms 3Solid Tumors 2Ovarian Neoplasms 2Neutropenia 2Neoplasms, Unknown Primary 2Laryngeal Neoplasms 2

Interventions

SHR-1701 1Paclitaxel 1Oxaliplatin 1Irinotecan 1Injections 1Fluorouracil 1Docetaxel 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Malignant Tumors × Fluorouracil × Clear all
NCT05235542 2022-08-11

A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors

Akeso

Phase 1/2 Unknown
130 enrolled

Advanced Malignant Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡